Pharmacokinetics of Selective Estrogen Receptor Modulators

@article{Morello2003PharmacokineticsOS,
  title={Pharmacokinetics of Selective Estrogen Receptor Modulators},
  author={K. Morello and Gregory T. Wurz and Michael W. DeGregorio},
  journal={Clinical Pharmacokinetics},
  year={2003},
  volume={42},
  pages={361-372}
}
  • K. Morello, Gregory T. Wurz, Michael W. DeGregorio
  • Published 2003
  • Medicine
  • Clinical Pharmacokinetics
  • Selective estrogen receptor modulators (SERMs) are a class of compounds used to treat and prevent breast cancer and osteoporosis. SERMs currently approved for use in patients include tamoxifen, toremifene and raloxifene. These compounds are well tolerated in patients, and the most common adverse effects experienced in patients undergoing SERM therapy include vasomotor symptoms such as hot flashes and vaginal discharge. New SERMs currently under development for use in the treatment and… CONTINUE READING
    145 Citations

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    The purpose of this study is to develop initial efficacy, feasibility, and safety data regarding the use of Tamoxifen in combination with amphotericin B and fluconazole in the… Expand
    ConditionsHiv, Meningitis, Meningitis Streptococcal, (+1 more)
    InterventionDrug
    Ospemifene use in postmenopausal women
    • 25
    Lasofoxifene, a new selective estrogen receptor modulator for the treatment of osteoporosis and vaginal atrophy
    • L. Gennari
    • Medicine
    • Expert opinion on pharmacotherapy
    • 2009
    • 30
    Lasofoxifene: a third-generation selective estrogen receptor modulator for the prevention and treatment of osteoporosis
    • 40
    Novel Selective Estrogen Receptor Downregulators (SERDs) Developed against Treatment-Resistant Breast Cancer.
    • 30
    Clinical Pharmacology of Lasofoxifene in Japanese and White Postmenopausal Women
    • 7
    Disposition of Lasofoxifene, a Next-Generation Selective Estrogen Receptor Modulator, in Healthy Male Subjects
    • 16
    • PDF
    Lasofoxifene, from the preclinical drug discovery to the treatment of postmenopausal osteoporosis
    • 3
    Pilot Study Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of the Combination of Exemestane and Tamoxifen
    • 16
    • PDF

    References

    SHOWING 1-10 OF 70 REFERENCES
    Pharmacokinetics of raloxifene and its clinical application.
    • D. Hochner-Celnikier
    • Medicine
    • European journal of obstetrics, gynecology, and reproductive biology
    • 1999
    • 121
    Tamoxifen and toremifene in breast cancer: comparison of safety and efficacy.
    • A. Buzdar, G. Hortobagyi
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 1998
    • 72
    Raloxifene: a selective estrogen receptor modulator.
    • 48